Physician profile
Perry A Moore
NPI 1447241831
$2,080.16
in general payments reported to CMS, 2019-2025
18 companies · $180 in 2025
The $180 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $59.93 · 2022: $1,148 · 2023: $536 · 2024: $156 · 2025: $180.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $872.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $872.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $616.99 | 2022-2023 | Axonics |
| Endo Pharmaceuticals INC. | $357.44 | 2021-2023 | Xiaflex, Aveed, Edex |
| Coloplast Corp | $230.72 | 2022-2024 | Speedicath |
| Teleflex LLC | $182.88 | 2023 | Urolift |
| Boston Scientific Corporation | $180.63 | 2021-2022 | |
| Procept Biorobotics Corporation | $153.79 | 2025 | |
| Sumitomo Pharma America, INC. | $70.41 | 2023 | Orgovyx |
| Astellas Pharma US INC | $58.51 | 2022-2023 | Myrbetriq |
| Medtronic, INC. | $38.58 | 2022 | |
| Janssen Biotech, INC. | $37.55 | 2022 | |
| Pfizer INC. | $27.96 | 2022-2023 | |
| Lilly USA, LLC | $26.46 | 2025 | Zepbound, Mounjaro |
| 180 Medical, INC. | $22.00 | 2023 | Gentlecath |
| Olympus America INC. | $20.64 | 2023 | Itind System |
| Abbvie INC. | $20.63 | 2023 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acerus Pharmaceuticals Corporation | $14.86 | 2022 | |
| Antares Pharma, INC. | $14.36 | 2022 | |
| Clarus Therapeutics INC. | $5.75 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Perry Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.